Carallia Brachiata

Carallia brachiata  (Lour.) Merr.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym C. integerrima DC. C. lucida Roxb. ex Kurz.
Habitat Throughout India, up to an altitude of 1,300 m, and in the Andamans.
Folk Karalli, Kierpa. Varanga (Malyalam).
Action Leaves—used in the treatment of sapraemia. Bark—used for treating oral ulcers, stomatitis, inflammation of the throat.
Taxonomic Cohort Genus Carallia (1 documented species); Family Unclassified (12 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Carallia brachiata (taxonomically cited with authority (Lour.) Merr.) is an established medicinal plant species in Indian materia medica. It is cataloged as a specialized classical drug entry within Indian medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. integerrima DC. C. lucida Roxb. ex Kurz, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India, up to an altitude of 1,300 m, and in the Andamans.

Across classical and vernacular Indian systems of medicine, Carallia brachiata is recognized under distinct polyglot nomenclature: in regional Indian folk and vernacular ethnobotany as Karalli, Kierpa. Varanga (Malyalam). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Carallia brachiata are: Leaves—used in the treatment of sapraemia. Bark—used for treating oral ulcers, stomatitis, inflammation of the throat. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Carallia brachiata establish the following evidence base: The leaves contain alkaloids (0.2% dry basis), the major being (+)-hygroline.

image2

Botanical Reference 1: Carallia brachiata — Botanical specimen

image3

Botanical Reference 2: Carallia brachiata — Botanical specimen

image3

Botanical Reference 3: Carallia brachiata — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Carallia brachiata stands as a distinct representative of the genus Carallia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

image1

Figure 1: Quantitative documentation profile across all 12 medicinal species of family Unclassified.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Carallia brachiata follow the plant-part modalities specified under its therapeutic action (Leaves—used in the treatment of sapraemia. Bark—used for treating oral ulcers, stomatitis, inflammation of the throat), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Carallia brachiata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top